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1992-271 MultipleStentslncreasesTargetVessel
RevaacularizetionRatas
D. Aliabadi, T.R. Bowere, F.V.Tilli, M. Spybrook, H.L. Greenberg,
J.A. Goldstein, C.L. Grines, R.D. Safian, W.W. O’Neill. William Beaurnorrt
Hospital, Royal Oak, Ml, USA
Recent trials have ahown that coronary stenting improves clinieel restenosis
compared with balloon angioplasfy. However, these trials included selected
lesion types with predominantly single stent implants. To determine whether
implantation of multiple stents influences clinical restenoais, we reviewed
the need for target vessel revaaularfzation (TVR) at 9 months in 316 con-
secutive patients who underwent intramronary stenting. A total of 585 stents
(436 Palmez-Schatz, 80 Billiaqt 69 Gianturco-Roubin) were implanted in 344
Ieaiona. Overall, W patients (19%) required TVR, in all cases related to in-
stent restenosis occurring Iata (>1 month) and presumably related to intimal
hyperplasia. To determine whether pre-proeedural angiographic features or
procedural factors influenced need for TVR, detailad angiographic anaiysia
were performed in 316 patients. By univariate analysis, angiographic corre-
lates of TVR included implantation of multiple overlapping stents at a single
target site (p c 0.01) non BENESTENT/STRESS equivalent (p < 0.01), and
target Ieaion length >lOmm (p < 0.04). Bymultivariata analysis, implantation
of multiple overlapping stents (OR 1.4 [1.0-1.6, gs~o Cl] p < 0.03) ramained
a predictor of need for TVR. The TVR rate for single stent implant was 117..
The TVR rate for implantation of 2 stents waa 23% (p <0.05 versus single
implant). For implantation of >2 stentS the TVR rate was 29% (p c 0.02
versus single stent).
Conclusion: The use of multiple overlapping stents increaaes the likali-
hocd of in-stent restenosis and tha naed for TVR.
D99228 SingleVersusMultiplePalmaz-SchatzStentImplentetion:ImmediateandFollow-upResults
1.Moussa’, C. Di Mario, J. Moaes 1, B. Reimera, S. Blengino, A. Colombo.
Centro Cuore Columbus, Milan, Italy, 1Lenox Hill Hospital, NY USA
Purpose: to evaluate outcome of patients undergoing single versus multiple
Palmaz-Schatz (PS) atent implantation. Methods: 575 consecutive pts (703
lesions) had PS stents implantad and expanded at high pressure. Lesions
withs 1stentcomprised group I (n =445) and Iesionswith >1 stentcomprised
group II (n= 256). Angiographic measurements were as follows:
Group I GroupH
Pre reference diametar (mm) 3.25 k 0.57 3.2S4C0.56
Pre MLD (mm) 1.07+ 0.57” 0.87+0.56*
Prs Lesionlength(mm) 7.67%4.13” 12.21 +S.32”
Final MLD (mm) 3,24 k 0.53 3.23 +0.60
*P <0.05 is consideredsignificant.MLD, minimumlumendiameter.
Procedural sueeesa was 96%. Stent thrombosis occurred in 6 pts, 0.7% in
group I and 1.9% in group II (P= O.12).Angiographic FUwas 73%at 5+ 2 mo
and clinical FU was 95’%0at 8 + 3 mo. Group II had higher restanosis (29%
vs 15Y0,p = 0.0004) USing >50Y0diameter StenOSiSCritefiOn and had higher
need for target lesion revascularization (20% vs 12%, p = 0.002) than group
L In conclusion, lesions requiring multiple stants have higher restenosis than
lesions treatad with a single stent, however this rate is improved from historic
reauits repotied with the use of multiple stents in tha era of low prassure
stent deployment.
1992-291 Short-TermOut@3me0fpatients”nder90in9
EndovascularCoronaryArterialReconstruction
V. Mathew, D. Hasdai, D.E. Grill, S.J. Melby, D.R. Holmes, Jr., P.B.Berger.
Mayo Clinic, Rcehestec MN, USA
The implantation of multiple cordigoua intracoronary stents is increasing
in frequency, although the outcome of such pts is not well described. We
reviewed our experience of 45 consecutive pts (mean 3.5 stentelpt, range 3-
6) without prior CABG orstenting who received 23stents in asinglecoronafy
artery. Palmaz-Schatz, Cook, and Wiktor stents were placed in 64%, 647.,
and 4% of pts, respectively. Indication for Stenting was threatenedacute
closure in 25 pts (56%); the treatad vessel was the RCA in 34 pts (76%).
Multivessel disease was presant in 26 pts (58%); other vessels were treated
in 6 pts (13%). As this included our early experience, 214 atms inflations
were used in only 30 pts (67Yo);warfarin was used post-stent in 25 pts (56%).
In-hospital events included death in 2 pts (4.4%), Q wave Ml in 1 pt (2.2%),
CABG in 2 pts (4.4%), stant occlusion in 4 pts (6.9%), and repeat target
vessel PTCA in 2 pta (4.4%); any of these occurred in 7 pts (15.6%). There
were 41 (91%) successful (no Q wave Ml or CABG) hospital survivors. No
further events occurred in the subsequent W days. Of successful hospital
survivors, 31 pts had ?6 month follow-up; in this period, death occurred in
1 (3.2%), Ml in 2 (6.5%), CABG in 1 (3.2%), stent occlusion in O, target
vessel PTCA in 5 (16.1%), savera angina in 7 (22.5Yo);8 pts (25.6%) had
z-1event. Conclusions: Implantation of multiple stents, even in the presence
of threatened/acute closure, is associated with a high initial success rate,
although early stent thrombosis was a problem. All early evente occurred
ip hospital. At 6 months of follow-up, multiple stent implantation appears to
have an acceptable event rate, although recurrent severe angina and the
need for repeat procedures are limitations of this strategy.
1992-SO]si~-Month~o,,o~-”POfpatientSwithMU!tipie
Stentsina SingleCoronaryArtery
E. Gaxiola, R.E. Vlietstra, K,F. Browne, D.G. Ebereole, A.S. Brenner,
T.T.Weeks, R.A. Kerensky. Watson C/inic, Lake/and, FL, USA, Univeraify of
Florida, Gainesville, FL, USA
Recent studies have shown that placement of a aingle coronary stent (S)
results in a decreased need for repeat target lesion revascularization (RTLR)
compared to PTCA. Placement of a single stent is also associated with high
initial success rates and excellent event free suwival (EFS); EFS is defined
as the absence of myocerdial infarction (Ml), death (D), repeat target Ieaion
angioplasty (RPTCA) or CABG, over a six-month follow-up. Many patients,
however, require multiple stents within a single corona~ artery. Outcome
data in patients receiving multiple stents are lacking. We compared event
free survival and RTLR (repeat PTCA or CABG) between patients (pta)
receiving 1 (n = 320) or multiple (22) adjacent Palmaz-Schatz stants in a
single coronary artery (2S = 115 pts; 3S = 15; 4S = 12; 5S = 3; 6S = 2). Pte
with acute major mmplieetions (n = 17) were excluded.
#sr#Pts EFS (“A) RPTCA (%) CABG (“A) RTLR % Ml (%) D (%)
1/320 275 036) 16 (5.6) 15 (4.7) 10,3 7 (2.2) S (2.6)
2/115 67 ~76j 16(13.9) 10 i6,7j 22.6 0 (0) 2 il.7j
22/147 110 (75) 19 (12.9) 13 (s.s) 21 ,s 2(1 .4) 3 (2.0)
?3/32 23 (72) 3 (9.4) 3 (9.4) 18.8 2 (6.2) 1 (3.1)
1S vs 2S: EFS p <0,025,RPTCA p c 0.01, RTLR p c 0.005, CABG p= NS,1S va 22S:
EFS p <0.01, RPTCA p <0.025, RTLR p <0.005, CABG p = NS; 2S VS ?2S p= NS; 2S
vs ?3S P = NS
Pts raceiving 2 or more stents in a single coronaty artery more frequently
required RTLR and had lower EFS than single stent pts. No difference wee
found in pts receiving 2S vs >2S. We conclude that pts requiring multiple
stents in a single coronaty artery have a lower EFS and significantly more
frequent requirement for RTLR compared with aingle stent pts. Using multiple
stents to decrease restenosis rate may not carry the same long-term benefits
demonstrated with single stents.
u993 Thrombotic Management:
Complication/Puncture Site Management
Tuesday, March 18, 1997, Noon–2:00 p.m.
Anaheim Convention Center, Hall E
Presentation Hour: Noon–1:00 p.m.
1993-1]BenefikOfAbCiXimabACCrUeintheFU,,speC~rUm
ofCoronaryIntarvantionalPatienta:Insightsfrom
the EPILOGTrial
J.E. Tcheng, A.M. Lincoff, D.P.Miller, J.E. Booth, M.M. Rund, C.F. Cabot,
H.F.Weisman, R.M. Califf, E.J. Topoi. Duke Urriv, Durham, NC, USA
The EPIC trial documented a 34.6Y0reduction at 30 days in ischemic com-
plications of coronary intervention with platelet GP llb/llla blockade with
abciximab (c7E3 Fab, ReoPro). The EPILOG trial of weight-adjusted c7E3
151 D<.oolD=.003 D=.041
unstsble stabls recent Ml
sngina ischemia (n=579)
(n=1328) (n=865)
Death, Ml, or urgentinterventionto 30 daya
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was conducted in 2792pta to evaluatefor further benefits in lower-risk
pts. Randomization was to placebo with standard-dose heparin, c7E3 with
standard-dose heparin, or c7E3 with low-dose (LD) heparin. Pta were cat-
egorized as having unstable angina, stable ischemia, or recent myocardial
infarction (Ml). Pts with a recent Ml were more likely to be male, younger,
and smokers, and were less likely to have diabetes, hypertension, or hy-
percholesterolemia (all p < 0.05). The primary endpoint by indication and
treatment group occurred as shown in the figure.
Coupled with the EPIC high-risk pt results, these data suggest that all pts
undergoing coronary intervention benefit from c7E3 treatment.
EJ9932 The Relationship Between Dissection Grade&Coronary Blood Flow as well as Other Angiographic
Outcomes After PTCA
K. Ryan, M. Rizzo, C. McLean, 1.Dotani, M. Goel, S. Marble, E. A1-Mousa,
W. Oaley,T. Dodge, M. Gibson, for the RESTORE lnVeSti9at0rS.WeSt.
Roxbury VAMC, Brigham & Women’s Hospital, Boston MA, USA
The relationship between post PTCA dissection grade & angiographic out-
comes wasexaminedin the RESTORE trial of Timfiban + heparln vs heparin
alone for 36 hrs. post PTCA in pts with acute coronary syndromes. The
frames fordyeto reach standardized distal Iandmarkawere counted to arrive
at the previously described Corrected TIMI Frame Count (CTFC), an index of
coronary flow. If no post PTCAdissection was present, the post PTCA CTFC
was 17.9 + 10.3, n = 818, whioh did not differ from the peat PTCA CTFC if a
mild dlssecfion (NHLBI type A = non-persistent Intraluminal radiolucency or
B = parallel tracts without peraietence) was present (18.2& 9.5, n = 228, p =
NS). The post PTCA CTFC of artefies with a severe dissection (NHLBI type
C = contrast outside lumen; D = spiral filling detect) was slower (21.4+ 13.7,
n = 69) than no dissection (p = 0.008) or mild dissection (p = 0.03). The risk
of abrupt clo.$ufewas higher in arteriea with typaa C/D dissection (10/112,
8.9%) than arteries with type A/B (6/363, 1.7%) or no dissection (17/1204,
1.4%)(P < 0.05). In contrast, the risk of restenosis was lower in patients
with type C/D dbsaction (W16, 37.5%) than type A/B (54/103, 52.4%) or no
dissection (166/295, 56.3%). Late MLD loss in type CID dissections (0.15
+ 0.66, n = 16) was also lower than that in type AJB dissections (0.63 +
0.67, n = 103, p = 0.009) or no dieaecfion (0.74 * 0.74, n = 295, p = 0.002).
Conokkdons:Type C & D dissections are associated with slower post PTCA
flow (~ CTFCS) and a higher risk of abrupt closure than type A & B or no
dissection, but with a lower risk of restenosis.
m9933 Incidence and management of coronary perforationin different coronary interventions
T. Fukutomi, T. Suzuki, H. Hosokawa, T. Tani. National ToyohashiFfigashi
Hospital, Toyohashi,Japan
The purpose of this study was to examine the incidence of coronary per-
foration (CP) complicating interventional procedures using either POBA or
New Devices, and to see the feasibility of developing management strategies
based on the nature of the perforation and their outcome. Angiographiedly,
CPdivided into two types: type 1characterized by epicardial ateining but with
no visible extravasating contrast jet, and type 2 with visible jet.
CP (“A) Type1 Type2 Tampo. Centssis PB CABG
POBA 2713,534 0.8 0.7 0.1 0.14 0.14 0,170
DCA 71376 1.9 0.3 1.6 1.3 1,3 1.6 0.3
Stent 5/366 1,4 0.6 0,5 1.1 l.t 0.5 0
Cuttina 6/538 1.1 0.4 0.7 0.4 0.4 0.9 0
ELCA- 3/13 23 23 0 0 0 23 0
Tempo:cardiactamponade,PB:perfusionballoon
Perforations complicating POBA were mostly type 1 and over one half of
the patients could be managed conservatively with intravenous hemostatic
agents, but type 2 complicated New Devices more frequently (POBA O.1%
vs. New Devices 0.9%, p < 0.0001). Because type 2 perforations often
progress to pericardial tamponade rapidly, all required pericardiocentesis.
The therapeutic strategy also included the use of the perfusion balloon
catheter, more often in type 2 perforations. By these procedures, there was
no death.
Conclusion: the risk of CP are increased “with the use of New Devices
compared to POBA, but in the great majority of patients, it could be managed
with perieardiocentesis, followed by catheter drainage in conjunction with
inflation of perfusion catheter.
H The Relationship Between Coronary Artery
Dissection and Long-term Clinical Outcome: Results
from the CRAC (Cornpliencs Related Acute
Complication) Trial
J.D. Talley,J. Blankenship, S. Wems, A. Spokojny, C. Landeau,
H.V.Anderson, H. White, R. Bach, R. Siegal, M. Krucoff, R. Raymond,
T. Little, T. Waites, S. Sharma, S. Warren, J. Bissett, C. Green, M. Rawert,
J. Pinkeston, M. Hope, for the CRAC investigators. UrrivofArkansaa, Litt/e
Rock, AR, USA
Coronaty artery dissection after elective PTCA may improve long-term pa-
tency and clinical status, if unaccompanied by complications. This relation-
ship was evaluated in the CRAC trial, a prospective, randomized study of
compliant (POC) and non-compliant (PET) balloon material in 1263 pts un-
dergoing elective PTCA at 35 centers. Dissection grade was determined by
the consensus of 2 of 3 reviawers. Clinical status was measured 6 months
after PTCA via postcard or phone cail.
No dissection Any dissection P
ER visit 25% 23% ns
Re-hoapitallzation 37% W“h ns
Ml 9% 8% ns
Re-Cath 25% 24% ns
CABG surgery 7% 10% na
Anginagrade 22 37% 34% ns
Hsaith Improved 76% 69% 0.0s
Thus: clinical status 6 months after eleorive’PTCA is not related to dis-
section of the coronary artery at the site of balloon dilatation.
~ Clinical, An~iOgraPhicand T~chnical~Orrela~SOf
Early Abrupt Vascular Closure During Coronary
Intervention
K.N. Garratt, D. Grill, M.R, Bell, P,B.Berger, D.R. Holmes, Jr.. Mayo C//rric,
Rochestec MN, USA
Alargeooronary intervention databank was interrogated to identify mrrelates
of in-hospital abrupt vaacular closure (AC). 592 pts with AC (TIMI grade O-1
blood flow) were identified. These pts were matched to 592 pts without AC
by age, gender, axtent of coronaty artey disease, and nearest procedure
date. Procedure type was categorized as balloon angioplaafy only (n =
1038 procedures), atherectomy (n = 91), laser angioplasty (n = 26), or
elective stent implantation (n = 27); patiants receiving stents to treat AC
were assignad to the procedure causing the AC event. Univariate analysis
identified myocardial infarction within 24 hra prior to procedure (P= 0.004),
emergency procedure (P= 0.026), and current cigarette smoking (P= 0.026)
as significant clinical correlates. Leaionthrombus (P = 0.0001) and angulation
(P= 0.02) were significant angiogrephic correlates; iesion calcification (P =
0.07) approached significance. Compared with all other devices combinad,
use of balloon angioplasty alone was associated with a significantly lower risk
of AC (P = 0.003). Relative to balloon angioptasty, an increased risk of AC
was found with atherectomy devices (odds ratio [OR] = 1.6, upper and lower
95% confidence intervals [Cl] = 1.16-2.8, P = 0.009) and laser devices (OR
=2.9, Cl= 1.2-7.0, P = 0.017) but elective corona~ stents neither increased
nor decreased AC risk (OR = 1.0, Cl = 0.46-2.14, P = 0.99). A multivariate
backward elimination regression model identified lesion thrombus (P = <
0.001), use of athereotomy devices (P= c 0.001), Iaserdevices (P = 0.004),
lesion angulation (P = 0.01) and cigarette smoking (P = 0.05) as correlates
of increased AC risk.
Conclusions: This large matched cohort study confirms discrete clinicai
and angiographic correlates of AC. Atherectomy and laser devices increase
AC risk, Elective stent implantation did not appear to reduce AC risk over
conventional balloon angioplasty; the small number of such pts studied may
have prevented any benefit from being observed.
=1 P~di~tO~Of~YOCardia,,nfarctiOn(~,]With
Percutaneous Revascularization in a Large
Multicenter Population
B.E. Tardiff, B. Mabe, N. Wildermann, M.H. Sketch, Jr., D.R. Holmes, Jr.,
E.M. Ohman, R.M. Califf. Duke Universi~ Durham, NC, USA
Percutaneous revascuiarization is often complicated by clinical or biochemi-
cal evidence of new myocardial necrosis. Certain patients may be at higher
riskforperi-procedural MIs, Reexamined demographic, clinical and anatomic
predictors of Mi in a pooied dataset of 6348 patients comprising 7 clinical
trials involving PTCA or DCA. 221 patients (4%) had an Ml on the same
day as the index intervention. Independent predictors of Ml after PTCA/OCA
were iimited to history of previous CABG, and graft identified as target vessel.
